| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/27/2001 | WO2001070940A1 Genetic constructs for regulated expression of insulin |
| 09/27/2001 | WO2001070939A1 Methods for transforming plant plastids and making transplastomic plants |
| 09/27/2001 | WO2001070932A2 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/27/2001 | WO2001070929A2 Transgenic plants containing heat shock protein |
| 09/27/2001 | WO2001070831A1 Magnetic, silanised polyvinylalcohol-basedcarrier materials |
| 09/27/2001 | WO2001070816A2 Ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | WO2001070815A1 Novel leukotriene b4 receptor |
| 09/27/2001 | WO2001070813A2 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 09/27/2001 | WO2001070812A2 Regulation of human histamine h2-like g protein-coupled receptor |
| 09/27/2001 | WO2001070811A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 09/27/2001 | WO2001070809A1 A novel polypeptide - protein 9 of growth hormone-family and a polynucleotide sequence encoding the same |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070806A2 Human secreted proteins and polynucleotides encoding the same |
| 09/27/2001 | WO2001070805A2 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them |
| 09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | WO2001070803A1 A novel polypeptide - human regulatory transcription factor 9.7 and a polynucleotide sequence encoding the same |
| 09/27/2001 | WO2001070802A1 A novel polypeptide, zinc finger protein 11 and the polynucleotide encoding thereof |
| 09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070797A1 Ligand-controlled anion channels of insects |
| 09/27/2001 | WO2001070796A1 A novel polypeptide, a human zinc finger protein 78 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070794A1 A novel polypeptide, a human zinc finger protein 11 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070793A1 A novel polypeptide, a human mitochondrial carrier protein 9 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070792A1 A novel polypeptide, a human tyrosinase 12 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070791A1 A novel polypeptide, a human nf-e2 relative factor 14 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070789A1 A novel polypeptide-human ribosomal protein s5-17 and the polynucleotide encoding said polypeptide |
| 09/27/2001 | WO2001070787A1 A novel polypeptide, a human transglutaminase 12 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070786A1 A novel polypeptide, a human tnfr/ngfr protein containing cytochrome c domain and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070785A1 A novel polypeptide, a human atp-dependent serine protein hydrolase 13 and the polynucleotide encoding the polypeptide |
| 09/27/2001 | WO2001070784A1 A novel polypeptide-human protein 17 containing chromo domain and the polynucleotide encoding said polypeptide |
| 09/27/2001 | WO2001070783A1 A novel polypeptide-human gamma-cop protein 16 and the polynucleoide encoding said polypeptide |
| 09/27/2001 | WO2001070781A1 A novel polypeptide-human ilf 13 and the polynucleotide encoding said polypeptide |
| 09/27/2001 | WO2001070780A1 A novel polypeptide-human ribosomal sii protein 12 and the polynucleotide encoding said polypeptide |
| 09/27/2001 | WO2001070779A1 A novel polypeptide-human cdc4 analogous protein and the polynucleotide encoding said polypeptide |
| 09/27/2001 | WO2001070778A2 Maize glycine rich protein promoter and use thereof |
| 09/27/2001 | WO2001070777A2 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | WO2001070776A2 Nimr compositions and their methods of use |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070773A2 Insecticidal peptides and methods for using same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070768A2 Receptor-binding compounds and method for identifying them |
| 09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
| 09/27/2001 | WO2001070766A2 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | WO2001070765A1 Receptor-binding compounds and methods for identifying them |
| 09/27/2001 | WO2001070641A1 Polymer coated surfaces for microarray applications |
| 09/27/2001 | WO2001070276A2 Aav5 vector for transducing brain cells and lung cells |
| 09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
| 09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
| 09/27/2001 | WO2001070253A1 Use of mia in immunotherapy |
| 09/27/2001 | WO2001070247A2 Salmonella vaccine materials and methods |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | WO2001070174A2 Vegf-modulated genes and methods employing them |
| 09/27/2001 | WO2001070032A1 Recombinant parainfluenza virus expression systems and vaccines |
| 09/27/2001 | WO2001070016A1 Animals with high histamine productivity |
| 09/27/2001 | WO2001037645A8 Transformation of ricinus communis the castor plant |
| 09/27/2001 | WO2001032856A3 Seed-preferred promoter from barley |
| 09/27/2001 | WO2001032855A9 Transgenic animal production using lopu-derived oocytes |
| 09/27/2001 | WO2001032126A3 Congenic animal models of non-insulin dependent diabetes mellitus |
| 09/27/2001 | WO2001032014A3 Use of salmonella vectors for vaccination against hellicobacter infection |
| 09/27/2001 | WO2001025421B1 Materials and method for detecting interaction of cftr polypeptides |
| 09/27/2001 | WO2001021802B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/27/2001 | WO2001020020A3 Method to identify herbicides, fungicides or plant growth regulators |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | WO2001019992A3 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 09/27/2001 | WO2001019990B1 Rip-3-like death-associated kinase |
| 09/27/2001 | WO2001019975A3 Plants having reduced activity in two or more starch-modifying enzymes |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
| 09/27/2001 | WO2001018232A3 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 09/27/2001 | WO2001018189A3 Method for expressing exogenous sequences in mammalian cells |
| 09/27/2001 | WO2001018056A3 Method of gene therapy for improving the efficiency of cancer therapy |
| 09/27/2001 | WO2001017547A3 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 09/27/2001 | WO2001016176A3 Transgenic animal model for neurodegenerative diseases |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014539A3 Methods and compositions for the construction and use of fusion libraries |
| 09/27/2001 | WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 09/27/2001 | WO2001014532A3 Alkaline bacillus amylase |
| 09/27/2001 | WO2001012840B1 Anti-epha2 antibodies as a cancer diagnostic |
| 09/27/2001 | WO2001011333B1 Apparatus for real-time measurement of cellular response |
| 09/27/2001 | WO2001010903A3 Proteases and protease inhibitors |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2001007589A3 Dna sequences encoding lipopeptide synthases |
| 09/27/2001 | WO2001007588A3 Dna sequences which code nodulation factors |
| 09/27/2001 | WO2001002430A3 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 09/27/2001 | WO2001000665A3 Inhibitors of memapsin 2 and use thereof |
| 09/27/2001 | WO2000057837A8 Compositions and methods for effecting the levels of cholesterol |
| 09/27/2001 | WO2000048004A9 High throughput mass spectrometry |
| 09/27/2001 | WO2000046386A9 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
| 09/27/2001 | US20010025380 Family of maize PR-1 genes and promoters |
| 09/27/2001 | US20010025379 Transgenic plant |
| 09/27/2001 | US20010025030 cDNA for human methylenetetrahydrofolate reductase and uses thereof |
| 09/27/2001 | US20010025026 Chimeric proteins for use in transport of a selected substance into cells |
| 09/27/2001 | US20010024834 Specific binding substances are disposed on a plurality of surfaces provided by substrate and arranged in direction of thickness of substrate |
| 09/27/2001 | US20010024831 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/27/2001 | US20010024830 Methods for the selective regulation of DNA and RNA transcription and translation by photoactivation |
| 09/27/2001 | US20010024829 Forming a complex of polyampholyte and polyion and delivering the complex into a cell; drug delivery |
| 09/27/2001 | US20010024827 Which express a neuron-specific marker and which can give rise to progeny which can differentiate into neuronal cells; for treatment of neuronal disorders |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024818 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |